此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

先天性膈疝的生理学脐带夹紧 (PinC)

2026年9月22日 更新者:Philip L.J. DeKoninck、Erasmus Medical Center

先天性膈疝婴儿的生理性脐带夹紧与立即脐带夹紧:一项多中心、随机对照试验

Pulmonary hypertension is a major determinant of postnatal survival in infants with a congenital diaphragmatic hernia (CDH). The current care during the perinatal stabilisation period in infants born with this rare birth defect might contribute to the development of pulmonary hypertension after birth - in particular umbilical cord clamping before lung aeration. An ovine model of diaphragmatic hernia demonstrated that cord clamping after lung aeration, called physiological-based cord clamping (PBCC), avoided the initial high pressures in the lung vasculature while maintaining adequate blood flow, thereby avoiding vascular remodelling and aggravation of pulmonary hypertension. The investigators aim to investigate if the implementation of PBCC in the perinatal stabilisation period of infants born with a CDH could reduce the incidence of pulmonary hypertension in the first 24 hours after birth.

The investigators will perform a multicentre, randomised controlled trial in infants with an isolated CDH. Before birth, infants will be randomised to either PBCC or immediate cord clamping, stratified by treatment centre and severity of pulmonary hypoplasia on antenatal ultrasound. For performing PBCC a purpose-designed resuscitation module (the Concord Birth Trolley) will be used.

研究概览

研究类型

介入性

注册 (实际的)

144

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Graz、奥地利
        • Medical University Graz
      • Bonn、德国
        • Universitätskrankenhaus Bonn
      • Mannheim、德国
        • Universitätsklinik Mannheim
      • Rome、意大利
        • Ospedale Pediatrico Bambino Gesu
      • Leuven、比利时
        • University Hospitals leuven
      • Melbourne、澳大利亚
        • Monash University
      • Stockholm、瑞典
        • Karolinska University Hospital
      • Nijmegen、荷兰
        • Radboudumc University Medical Center
      • Rotterdam、荷兰
        • Erasmus MC University Medical Center - Sophia Children's Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

8个月 及以上 (孩子、成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Left-sided CDH
  • Isolated CDH: no associated structural or genetic abnormalities that are diagnosed before birth
  • Gestational age at delivery ≥35.0 weeks
  • Parental written informed consent

Exclusion Criteria:

  • Right-sided or bilateral CDH
  • Gestational age at delivery <35.0 weeks
  • Maternal contraindications: anterior placenta praevia, placental abruption
  • High urgency caesarean section, with intended interval to delivery <15 min
  • Cases that have been treated during pregnancy with experimental drug therapy aiming to decrease the occurrence of pulmonary hypertension
  • Twin pregnancies in which the infant diagnosed with a CDH is born first
  • Multiple birth >2 (triplets or higher order)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Physiological-based cord clamping

In PBCC, the Concord will be placed next to the bed of the mother and all equipment will be checked before the second stage of labour has started. The infant will be placed on the platform of the Concord immediately after birth, avoiding any traction or pressure on the cord and avoiding heat loss by radiation heating. The umbilical cord will not be clamped until the infant is considered respiratory stable, which is defined as the presence of a heart rate >100 bpm and preductal oxygen saturation >85%, while using an fraction of inspired oxygen (FiO2) of <0.5. The minimum and maximum times of cord clamping are three and ten minutes after birth, respectively. Oxytocin administration will be postponed until after cord clamping if there are no obstetric concerns. At any time, the attending neonatologist and obstetrician can decide that PBCC should not be performed or be interrupted. In that case, the infant can be placed on the standard resuscitation table for (further) stabilisation.

See 'Arm'

无干预:Immediate cord clamping

In the immediate cord clamping group, the cord will be clamped immediately after birth. The infant will then be transferred to the standard neonatal resuscitation table. After cord clamping, all infants will be managed according to the standardised neonatal management protocol for infants with a CDH, which is a consensus of current clinical guidelines by the CDH EURO consortium.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Number of participants with pulmonary hypertension diagnosed in the first 24 hours after birth.
大体时间:First 24 hours after birth

Pulmonary hypertension is present if at least 2 of the following 4 criteria are present or if the infant requires extracorporeal membrane oxygenation (ECMO) in the first 24 hours after birth:

  1. Right ventricular systolic pressure (RVSP) ≥2/3 systemic systolic pressure*
  2. Right ventricle (RV) dilatation/septal displacement or RV dysfunction +/- left ventricle (LV) dysfunction*
  3. Pre-post ductal SpO2 difference >10% for at least 15 consecutive minutes
  4. Oxygenation Index >20** *as found on first ultrasound in first 24 hours after birth; **highest value measured in first 24 hours after birth

The following echocardiographic parameters will be collected to objectify these criteria:

  • RV size
  • Pulmonary artery acceleration time (PAAT), right ventricular ejection time (RVET), PAAT:RVET ratio
  • Intraventricular septum configuration
  • LV systolic eccentricity index
  • Mean airway pressure
  • PaO2
  • FiO2
  • Preductal+postductal SpO2
First 24 hours after birth

次要结果测量

结果测量
措施说明
大体时间
Neonatal: mortality before discharge from the tertiary care hospital
大体时间:From birth till discharge from the tertiary care hospital, through study completion an average of one year

Number of patients that died before discharge

From birth till discharge from the tertiary care hospital, through study completion an average of one year
Neonatal: presence of 3 or more criteria for pulmonary hypertension or extracorporeal membrane oxygenation within 24 hours after birth
大体时间:The first 24 hours after delivery

Number of patients with 3 or more criteria or ECMO

The first 24 hours after delivery
Neonatal: number of patients requiring ECMO therapy
大体时间:From admission to the ICU until the date of death or the date of discharge home, whichever came first

Number of patients requiring ECMO therapy

From admission to the ICU until the date of death or the date of discharge home, whichever came first
Neonatal: number of days of duration of supplemental oxygen need
大体时间:From admission to the ICU until the date of discharge to another ward or home, whichever came first,through study completion an average of one year

Number of days of duration of supplemental oxygen need

From admission to the ICU until the date of discharge to another ward or home, whichever came first,through study completion an average of one year
Neonatal: number of days of duration of mechanical ventilation
大体时间:From admission to the ICU until the date of discharge to another ward or home, whichever came first,through study completion an average of one year

Number of days of duration of mechanical ventilation

From admission to the ICU until the date of discharge to another ward or home, whichever came first,through study completion an average of one year
Neonatal: duration of admission to the tertiary care hospital
大体时间:From admission to the ICU until the date of discharge to another ward or home, whichever came first

Number of days of admission to the tertiary care hospital

From admission to the ICU until the date of discharge to another ward or home, whichever came first
Maternal: number of patients with postpartum haemorrhage
大体时间:The first 24 hours after delivery

Postpartum haemorrhage is defined as estimated blood loss >1000 mL

The first 24 hours after delivery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2020年5月11日

初级完成 (实际的)

2026年1月1日

研究完成 (实际的)

2026年1月15日

研究注册日期

首次提交

2020年4月14日

首先提交符合 QC 标准的

2020年4月30日

首次发布 (实际的)

2020年5月5日

研究记录更新

最后更新发布 (实际的)

2026年9月25日

上次提交的符合 QC 标准的更新

2026年9月22日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅